WST - Company ID 0000105770
The table below shows WEST PHARMACEUTICAL SERVICES INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $521.40M | $628.50M | $509.70M | $404.20M | $490.90M | $446.20M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $685.60M | $625.00M | $582.40M | $543.60M | $524.30M | $479.40M |
| Inventory | $452.60M | $438.00M | $421.10M | $388.70M | $401.20M | $419.20M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.83B |
| $1.82B |
| $1.68B |
| $1.46B |
| $1.55B |
| $1.48B |
| Property, plant & equipment | $1.70B | $1.74B | $1.72B | $1.63B | $1.57B | $1.49B |
| Goodwill | $109.20M | $110.60M | $110.90M | $107.50M | $108.80M | $107.30M |
| Total assets | $4.11B | $4.11B | $3.95B | $3.62B | $3.68B | $3.49B |
| Accounts payable | $252.30M | $255.80M | $239.00M | $228.40M | $224.30M | $211.70M |
| Total current liabilities | $674.00M | $635.40M | $604.60M | $526.70M | $516.50M | $633.70M |
| Long-term debt | $202.80M | $202.70M | $202.60M | $202.60M | $202.60M | $72.90M |
| Total liabilities | $1.12B | $1.05B | $1.02B | $935.10M | $923.00M | $912.60M |
| Retained earnings | $4.48B | $4.26B | $4.14B | $4.03B | $3.86B | $3.72B |
| Total equity | $2.99B | $3.05B | $2.93B | $2.68B | $2.75B | $2.58B |